AMPK | adenosine monophosphate-activated protein kinase |
ASGR1 | asialoglycoprotein receptor 1 |
CKM | cardiovascular-kidney-metabolic |
CVD | cardiovascular disease |
GLP-1RA | glucagon-like peptide-1 receptor agonists |
MR | Mendelian randomization |
mTOR | mechanistic target of rapamycin |
RCT | randomized controlled trial |
SGLT2 | sodium–glucose cotransporter-2 |